CCHT Biopharmaceutical

Changchun High-Tech Industries (Group) Inc. is a leading Chinese biopharmaceutical conglomerate primarily focused on the development, manufacturing, and commercialization of innovative biologics and vaccines. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals (GenSci), which is a dominant player in the Chinese recombinant human growth hormone market, and Changchun BCHT Biotechnology, a major developer of vaccines for infectious diseases. Its product portfolio includes treatments for growth disorders, infertility, and various viral infections, alongside a growing pipeline in oncology and immunology. Headquartered in Changchun, China, the group is a significant player in the domestic life sciences sector and is publicly traded on the Shenzhen Stock Exchange.